Rotational atherectomy is only an interim strategy.

Original title: High-Speed Rotational Atherectomy Before Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary Lesions. The Randomized ROTAXUS (Rotational Atherectomy Prior to Taxus Stent Treatment for Complex Native Coronary Artery Disease) Trial. Reference: Mohamed Abdel-Wahab et al. J Am Coll Cardiol Intv 2013; article in press

Heavily calcified lesions are difficult and may prevent the appropriate expansion of a drug-eluting stent (DES) with consequent increased risk of thrombosis and/or restenosis. 

Besides this type of injury may also damage the DES polymer and produce an inadequate diffusion of the drug to the subintimal. Rotational atherectomy, (RA), can effectively ablate these plates which could improve the effectiveness of a DES in this context. 

Rotablator was used (Boston Scientific Scimed, Maple Grove, Minnesota) with a chosen size of catheter to achieve a relationship with the size of the vessel 0.5. The primary endpoint was late lumen loss at nine months of angiographic follow-up. 240 patients were randomized with de novo lesions and moderate to severe calcification and Taxus versus rotational atherectomy and Taxus. 

The clinical and angiographic characteristics were well balanced between the groups. Making an analysis by treatment intention, angiographic success was identical, (96.7%), but considering that 12.5% of randomized patients to standard dilation finally received RA, the ultimate results achieved was significantly better for RA (92.5% versus 83.3%, P = 0.03). 

A 9 month follow-up of cardiac events (MACE) was similar in both groups, (24.2% versus standard. RA 28.3%, P = 0.46), as well as late lumen loss (primary endpoint) with 0.31 ± 0.52 mm versus standard group and 0.44 ± 0.58 mm for RA (p = 0.04).

Conclusion 

In this study routine rotational atherectomy prior to Taxus stent implantation in calcified lesions was not superior to Taxus stent implantation only.

Editorial Comment:

ROTAXUS is the first randomized, controlled trial testing routine rotational atherectomy prior to DES and probably evaluated a population with more complex anatomy which has been included in the job with stents. Considering the results, the high volume at centers and the great experience of the surgeons involved, we would say that the use of rotational atherectomy is just a rescue strategy. However, the “standard strategy” was to dilate to high atmospheres using not self-righteous balloons. Despite this, there was a high crossover. While it is true that rotational atherectomy does not improve performance in monitoring, it does change impatient procedure success in this type of injury.

SOLACI.ORG

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...